Nicholas Investment Partners’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-235,855
Closed -$8.77M 177
2020
Q3
$8.77M Buy
235,855
+202,240
+602% +$8.01M 0.95% 36
2020
Q2
$1.73M Sell
33,615
-52,503
-61% -$2.2M 0.37% 110
2020
Q1
$2.71M Buy
86,118
+17,548
+26% +$926K 0.53% 80
2019
Q4
$4.09M Buy
+68,570
New +$3.08M 0.45% 82
2019
Q1
Sell
-8,353
Closed -$384K 216
2018
Q4
$384K Sell
8,353
-65,718
-89% -$3.17M 0.04% 210
2018
Q3
$3.29M Sell
74,071
-949
-1% -$43.6K 0.26% 149
2018
Q2
$2.94M Buy
75,020
+6,272
+9% +$317K 0.21% 157
2018
Q1
$4.97M Buy
+68,748
New +$5.05M 0.36% 84
2015
Q3
Sell
-60,630
Closed -$4.96M 303
2015
Q2
$4.96M Sell
60,630
-12,279
-17% -$1.2M 0.32% 106
2015
Q1
$6.75M Buy
72,909
+32,805
+82% +$2.12M 0.42% 63
2014
Q4
$1.62M Buy
40,104
+16,034
+67% +$491K 0.1% 262
2014
Q3
$589K Buy
+24,070
New +$383K 0.04% 291

Other funds holding ESPR